David J. Wambeke - Nov 16, 2023 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role: Chief Business Officer
Signature: /s/ Amy E. Culbert, attorney-in-fact
Stock symbol: DMAC
Transactions as of: Nov 16, 2023
Transactions value $: $49,200
Form type: 4
Date filed: 11/16/2023, 04:37 PM
Previous filing: Jun 26, 2023
Next filing: Jun 3, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DMAC	Voting Common Shares, no par value per share	Purchase	$49.2K	+20K	+3.94%	$2.46	527K	Nov 16, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.